Open-Label CA-008 (Vocacapsaicin) in Bunionectomy
Public ClinicalTrials.gov record NCT03885596. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Study of Intraoperative CA-008 Administration in Subjects Undergoing Bunionectomy
Study identification
- NCT ID
- NCT03885596
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Concentric Analgesics
- Industry
- Enrollment
- 36 participants
Conditions and interventions
Conditions
Interventions
- CA-008 Drug
- Ketorolac Drug
- Acetaminophen IV Drug
- Fentanyl Drug
- Bupivacaine Hydrochloride Drug
- Lidocaine HCl Drug
- Celecoxib Drug
- Acetaminophen Oral Drug
- Lidocaine Hydrochloride Drug
- Exparel Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 24, 2019
- Primary completion
- Jul 1, 2019
- Completion
- Oct 21, 2019
- Last update posted
- Oct 26, 2021
2019
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lotus Clinical Research, LLC | Pasadena | California | 91105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03885596, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2021 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03885596 live on ClinicalTrials.gov.